Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France

Post Views: 212 Publication  de la fameuse étude CNAM  First published: 25 September 2018 – Christophe Chaignot, Mahmoud Zureik, Grégoire Rey, Rosemary Dray‐Spira, Joël Coste, Alain Weill https://onlinelibrary.wiley.com/doi/abs/10.1002/pds.4635 Malgré un article …

Plus d'infos